Macquarie Group’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-15,406
Closed -$6K 2282
2018
Q4
$6K Sell
15,406
-74,155
-83% -$43.7K ﹤0.01% 2086
2018
Q3
$90K Sell
89,561
-276,591
-76% -$271K ﹤0.01% 1614
2018
Q2
$439K Sell
366,152
-65,360
-15% -$90.6K ﹤0.01% 1401
2018
Q1
$712K Sell
431,512
-29,980
-6% -$43.5K ﹤0.01% 1275
2017
Q4
$623K Sell
461,492
-37,141
-7% -$51.3K ﹤0.01% 1373
2017
Q3
$748K Buy
+498,633
New +$788K ﹤0.01% 1311

Other funds holding HLTH

Macquarie Group's HLTH Position: Q1 2019 in Review

Macquarie Group sold out of Nobilis Health Corp. (HLTH) in Q1 2019, closing a stake of 15,406 shares — an estimated $6K sold.

Macquarie Group first reported a position in HLTH in Q3 2017 and held it in 6 quarters. The position peaked at $748K in Q3 2017. 26 funds tracked by Wall St. Rank hold HLTH as of Q1 2019.

  • Macquarie Group reported no remaining Nobilis Health Corp. position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 15,406 Nobilis Health Corp. shares in Q1 2019, an estimated $6K.
  • Macquarie Group first reported a position in Nobilis Health Corp. in Q3 2017 and held it in 6 quarters.
  • Macquarie Group's Nobilis Health Corp. position peaked at $748K in Q3 2017.
  • 26 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.